In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that it could potentially serve as an alternative to long-term blood thin | Boston ...
Boston Scientific (BSX) stock tumbled 9% to two-year lows after Watchman trial data revealed stroke concerns and Raymond ...
(Ad) Peter Smith lives an active life. At 67, he loves to garden, work outside with his hands and get out on his bicycle. So, when doctors told him he couldn’t cycle anymore due to the blood thinners ...
Apr. 9—Medical Center Hospital is proud to announce that Dr. Manohar Angirekula, Dr. Adam Farber and Dr. Fernando Boccalandro successfully implanted the first WATCHMAN FLX Pro Device on April 1. MCH ...
MedPage Today on MSN
Watchman LAA Occluder Bounces Back as Alternative to OAC in CHAMPION-AF
Study suggests a path forward for device therapy, though caveats are plenty ...
TOPEKA, Kan. (WIBW) - A little device is giving some people at risk for a stroke big peace of mind. It’s called the Watchman. It’s become a more frequent option for people with a heart condition ...
In the showdown between left atrial appendage (LAA) closure devices, the Amplatzer Amulet outperformed Watchman for peridevice leaks (PDL) in one trial longer term but not in another. At 12 months of ...
Women have more in-hospital complications than men and double the risk for major adverse events after left atrial appendage occlusion (LAAO) with the Watchman device, according to new National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results